Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Review of Marathon

<< Previous

Bullboard Posts

Next >>

Comment by Momo25on Jul 31, 2023 10:24am

66 Views

Post# 35564618

RE:RE:RE:RE:RE:RE:Review of Marathon

Speceo likes ping glasses. Give me your address I will send you a brand new one. As usual, with his wishful thinking, TH could find a partner or at worst could sell shares to pay back Marathon. No serious company would partner with a so failing company. No smart investor wants to buy TH shares anymore, even you, SPECEO, wouldn't put a penny in this stock. Your fund is almost bankrupt.

<< Previous

Bullboard Posts

Next >>

Advancing an underexplored area of the Yukon with the same geology as B.C’.s Golden Triangle